Adding a laser sight, the Viridian Green Laser R5-G42 Reactor, easily brought about better accuracy in our shooters. “With a ...

The crew of Delta flight 2088 from Austin, Texas reported the aircraft was struck by a green laser Sunday night about 9 miles ...

Devices will be important for applications in quantum sensing and computing, biology, underwater communications and display ...

Viridian Therapeutics said Tuesday that an experimental treatment improved the signs and symptoms of thyroid eye disease — results that achieved the primary goals of a Phase 3 clinical trial and ...

Viridian Therapeutics (NASDAQ:VRDN) added ~26% to reach the highest level since March on Tuesday as Wall Street reacted to topline results from its THRIVE Phase 3 clinical trial for its lead ...

Viridian anticipates submitting an FDA marketing application for veligrotug for thyroid eye disease in 2H 2025. TED is an autoimmune condition characterized by inflammation, growth, and tissue ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Yee estimates potential peak sales of $2 billion for Viridian's drug as a treatment for TED. Tepezza generated sales of $479 million in the three months ended June 30. Amgen had gained the drug ...

Analyst Jason Butler of JMP Securities reiterated a Buy rating on Viridian Therapeutics (VRDN – Research Report), boosting the price target to $38.00. Jason Butler has given his Buy rating due ...